Xiaochun Wan

11PUBLICATIONS
25CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 07, 2025
TRIM11 potentiates antitumor immunity via inhibition of the IFN-γ/PD-L1 axis.

Yingying Xu, Runjie Cai, Maoxuan Liu

|Nov 06, 2025
Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head.

Junxin Li, Min Wang, Yang Yang

|Oct 06, 2025
NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α.

Pengchao Zhang, Jian Cheng, Zhao Liu

|Mar 27, 2025
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy.

Abdulrahman Ibrahim, Nada Mohamady Farouk Abdalsalam, Zihao Liang

|Jan 20, 2025
CRISPR knock-in of a chimeric antigen receptor into GAPDH 3'UTR locus generates potent B7H3-specific NK-92MI cells.

Liujiang Dai, Pengchao Zhang, Xiangyun Niu

|Oct 14, 2024
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.

Lawan Rabiu, Pengchao Zhang, Lukman O Afolabi

Pageof 2

Frequent Collaborators

5 joint publications

Guizhong Zhang

3 joint publications

Dehong Yan

2 joint publications

Guang Yu

2 joint publications

Xiaolu Yang